Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.

Brain pathology (Zurich, Switzerland) - 1 Mar 2022

Mawrin Christian, Koch Ralf, Waldt Natalie, Sandalcioglu I Erol, Braunsdorf Werner E K, Warnke Jan-Peter, Goehre Felix, Meisel Hans-Jürgen, Ewald Christian, Neyazi Sina, Schüller Ulrich, Kirches Elmar

Abstract excerpt

Meningiomas are the most frequent primary intracranial tumors. The considerable variety of histological subtypes has been expanded by the definition of molecular alterations, which can improve both diagnostic accuracy and determination of individual patient's outcome. According to the upcoming WHO classification of brain tumors, the in-time analysis of frequent molecular events in meningiomas may become mandatory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosomal Proteins, Non-Histone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to High-Throughput Nucleotide Sequencing

Share to Homozygote

Share to Meningeal Neoplasms

Share to Meningioma

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35213080
DOI: 10.1111/bpa.13046
PMCID: PMC8877726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.PMID 35213080Read ↗

Molecular alterations in meningioma: prognostic and therapeutic perspectivesSemantic proximity Read ↗

Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.Semantic proximity Read ↗

[Clinicopathological and molecular features of meningioma: an analysis of 134 cases based on high-throughput sequencing].Semantic proximity Read ↗

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionSemantic proximity Read ↗

Genetic landscape of meningioma.Semantic proximity Read ↗

Meningioma genomics: a therapeutic challenge for cliniciansSemantic proximity Read ↗

Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.Semantic proximity Read ↗

Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.Semantic proximity Read ↗

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic ApplicationsSemantic proximity Read ↗

Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.Semantic proximity Read ↗

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.Semantic proximity Read ↗

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.